Valuation: Agilent Technologies, Inc.

Market Cap 39.18B 34.06B 31.7B 29.1B 54.96B 3,740B 55.81B 374B 147B 1,862B 147B 144B 6,243B P/E 2026 *
27x
P/E 2027 * 23.6x
Enterprise Value 39.98B 34.76B 32.35B 29.7B 56.09B 3,817B 56.96B 381B 150B 1,900B 150B 147B 6,372B EV / Sales 2026 *
5.37x
EV / Sales 2027 * 4.91x
Free-Float
99.81%
Yield 2026 *
0.74%
Yield 2027 * 0.79%
07-23 Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers MT
07-21 Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift RE
07-20 HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited CI
07-14 Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma CI
07-14 Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers MT
07-13 Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating MT
07-08 Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis CI
07-06 Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 MT
07-01 Agilent Technologies Launches Xcelligence RTCA Esight AI Module CI
06-26 Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron… Zonebourse
06-25 Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 CI
06-25 Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. CI
06-25 Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group MT
1 day-0.60%
1 week-0.69%
Current month+3.61%
1 month+3.17%
3 months+20.17%
6 months+1.65%
Current year+1.14%
1 week 135.78
Extreme 135.78
142.42
1 month 125
Extreme 125
142.42
Current year 108.35
Extreme 108.35
150.1
1 year 108.35
Extreme 108.35
160.27
3 years 96.43
Extreme 96.43
160.27
5 years 96.43
Extreme 96.43
179.57
10 years 42.92
Extreme 42.92
179.57
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-20
Director of Finance/CFO 49 2025-11-16
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Chairman 75 2017-03-15
Director/Board Member 78 2010-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap.
2/27/26 Tax

Chief Executive Officer

279 0.0001%
2/27/26 Tax

Executive/Senior Manager

89 0.0000%
2/27/26 Tax

Executive/Senior Manager

124 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%-0.69%+19.87%+13.02% 39.18B
-0.97%+0.53%+22.15%+4.12% 214B
-0.31%+2.15%-0.78%-23.30% 138B
+0.18%+4.47%-26.71%+8.69% 125B
-1.01%+2.58%-56.74%-12.46% 68.37B
-1.00%+3.79%+8.13%+4.50% 50.05B
-0.91%+5.13%-22.07%-30.22% 47.67B
-0.76%+0.73%+30.71%+36.65% 37.34B
-2.95%+11.70%-5.12%-13.24% 31.59B
+0.70%+7.30%-22.95%-5.77% 30.08B
Average -0.80%+7.51%-5.35%-1.80% 78.12B
Weighted average by Cap. -0.69%+7.65%-2.74%-2.59%

Financials

2026 *2027 *
Net sales 7.45B 6.47B 6.03B 5.53B 10.45B 711B 10.61B 71.04B 27.88B 354B 27.97B 27.36B 1,187B 7.9B 6.87B 6.39B 5.87B 11.08B 754B 11.26B 75.36B 29.57B 375B 29.67B 29.02B 1,259B
Net income 1.47B 1.27B 1.19B 1.09B 2.06B 140B 2.09B 13.98B 5.49B 69.65B 5.5B 5.38B 234B 1.63B 1.42B 1.32B 1.21B 2.29B 156B 2.33B 15.59B 6.12B 77.69B 6.14B 6B 260B
Net Debt 807M 702M 653M 600M 1.13B 77.06B 1.15B 7.7B 3.02B 38.37B 3.03B 2.97B 129B -401M -349M -325M -298M -563M -38.29B -571M -3.83B -1.5B -19.06B -1.51B -1.47B -63.92B
Logo Agilent Technologies, Inc.
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.2%) and services (28.8%). Net sales are distributed geographically as follows: the United States (33.7%), China and Hong Kong (17.6%) and other (48.7%).
Employees
18,000
Date Price Change Volume
26-07-31 US$137.62 -0.79% 587,606
26-07-30 US$138.71 -1.13% 1,955,110
26-07-29 US$140.30 -0.17% 1,864,630
26-07-28 US$140.54 +1.92% 2,277,365
26-07-27 US$137.89 -0.49% 1,830,515
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
138.71USD
Average target price
159.32USD
Spread / Average Target
+14.86%

Quarterly revenue - Rate of surprise